NCT00283036已完成4 期
Efficacy and Tolerability of Posology Adaptation of Irbesartan in Ambulatory Hypertensive Patients
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Arterial Tension
研究概览
简要总结
Study objective : To compare efficacy and tolerability of posology adaptation of Irbesartan in ambulatory Hypertensive patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with mild or moderate hypertension defined with arterial diastolic pressure (PAD) at sit position between 90 mmHg and 110 mmHg and arterial systolic pressure (PAS) at sit position between 140 mmHg and 180 mmHg.
- •Patient diagnosed after 3 consultations within 2 months who has never been under treatment and responding to the required conditions for hypertension treatment with irbesartan. This patient must has been under proper but insufficient hygieno dietetic diet
- •Patient who has been under a none satisfied antihypertensive treatment, and for whom this treatment was stopped at least 2 weeks prior to inclusion.
- •Patient with a laboratory analysis (urinary sediment- Na -K- creatinine, total cholesterol) and ECG during the month prior to inclusion.
排除标准
- •Severe Hypertension defined by PAS > 180mmHg and/or PAD > 110 mmHg.
- •Isolated systolic Hypertension
- •Secondary Hypertension
- •Arterial stenosis on unique kidney - arterial bilateral kidney stenosis
- •Non-surgically sterilized women or non-menopaused women.
- •Confirmed sodic depletion.
- •Hypersensitivity to Irbesartan.
- •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
结局指标
主要结局
Arterial Tension
Tolerability
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4Acute Myeloid LeukemiaNCT02473146Versailles Hospital225
Unknown
不适用
Prepackaged Nutritional Formulations Versus Restricted Diet for Bowel PreparationBowel PreparationNCT04776733Ningbo No. 1 Hospital196
已完成
不适用
Tolerability of Using a Post-Treatment Topical Adjuvant Combination Following Fractional Radiofrequency AblationSkin DisordersNCT02896569Venus Concept49
Unknown
不适用
Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and GauzeWound InfectionWound HealWounds and InjuriesNCT04596124Farmaceutici Damor Spa116
已完成
不适用
Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 OriginsHyperpigmentationNCT06253455Cosmetique Active International67